Hypertension Management in the Diabetes Patient
| Autor: | Stephen W. Durst, Deb Schering |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
medicine.medical_specialty
Type 1 diabetes business.industry Pharmacist Type 2 Diabetes Mellitus Type 2 diabetes Disease medicine.disease 030226 pharmacology & pharmacy Diabetic nephropathy 03 medical and health sciences 0302 clinical medicine Blood pressure Diabetes mellitus medicine Physical therapy Pharmacology (medical) 030212 general & internal medicine business Intensive care medicine |
| Zdroj: | Journal of Pharmacy Practice. 17:55-60 |
| ISSN: | 1531-1937 0897-1900 |
| Popis: | Approximately 11 million of the 17 million US citizens with type 2 diabetes mellitus also have hypertension. The development of diabetic nephropathy in patients with type 1 diabetes is frequently associated with hypertension, and both may present several years after the onset of diabetes. In type 2 diabetes, hypertension may precede the development of diabetes by several years. Differences that exist between type 1 and type 2 diabetes and the development of hypertension may indicate differences in the concomitant disease processes, yet the inevitable development of both diseases contributes to significant increases in risk of cardiovascular disease.The pharmacist must be familiar with blood pressure treatment goals in the hypertensive-diabetic patient and appropriate pharmacotherapeutic management. This article outlines treatment goals in the patient with diabetes and concurrent hypertension, reviews trials assessing pharmacologic treatments, and provides a summary of monitoring parameters to guide the pharmacist in the management of this population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|